SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
12-Jul-24 5:46 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 10-Jul-24 | Option Exercise | 12,923 | $14.55 | $188,077.00 | 1% 1.06M to 1.07M | |
12-Jul-24 5:46 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 10-Jul-24 | Planned Option Sale | 12,923 | $22.49 | $290,598.00 | (1%) 1.07M to 1.06M | |
26-Jun-24 5:07 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 24-Jun-24 | Option Exercise | 12,930 | $14.42 | $186,451.00 | 1% 1.06M to 1.07M | |
26-Jun-24 5:07 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 24-Jun-24 | Planned Option Sale | 12,930 | $23.10 | $298,711.00 | (1%) 1.07M to 1.06M | |
12-Feb-24 8:22 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 08-Feb-24 | Private Sale (Planned) | 92,001 | $27.13 | $2,495,820.00 | (8%) 1.15M to 1.06M | |
25-Jan-24 4:59 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 23-Jan-24 | Market Sale (Planned) | 5,696 | $18.41 | $104,851.00 | (< 1%) 1.16M to 1.15M | 1% |
08-Jan-24 4:19 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 05-Jan-24 | Sale (Planned) | 28,237 | $19.57 | $552,478.00 | (2%) 1.19M to 1.16M | |
08-Jan-24 4:19 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 04-Jan-24 | Private Sale (Planned) | 40,732 | $20.31 | $827,202.00 | (3%) 1.23M to 1.19M | |
08-Jan-24 4:19 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 18-Dec-23 | Market Sale (Planned) | 4,702 | $18.13 | $85,242.60 | (< 1%) 1.23M to 1.23M | (< 1%) |
08-Jan-24 4:19 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 15-Dec-23 | Market Sale (Planned) | 28,632 | $17.27 | $494,432.00 | (2%) 1.26M to 1.23M | (5%) |
04-May-23 10:00 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 02-May-23 | Gift | 600,000 | -- | -- | 32% 1.86M to 2.46M | |
04-May-23 10:00 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 02-May-23 | Gift | 600,000 | -- | -- | (24%) 2.46M to 1.86M | |
23-Feb-23 7:56 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 22-Feb-23 | Sale (Planned) | 16,449 | $20.22 | $332,665.00 | (< 1%) 1.88M to 1.86M | |
23-Feb-23 7:56 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 21-Feb-23 | Private Sale (Planned) | 17,997 | $20.96 | $377,209.00 | (< 1%) 1.89M to 1.88M | |
23-Jan-23 7:57 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 20-Jan-23 | Sale (Planned) | 8,625 | $20.19 | $174,127.00 | (< 1%) 1.9M to 1.89M | |
23-Jan-23 7:57 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 19-Jan-23 | Private Sale (Planned) | 10,899 | $20.03 | $218,347.00 | (< 1%) 1.91M to 1.9M | |
19-Dec-22 5:56 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 16-Dec-22 | Sale (Planned) | 53,944 | $23.02 | $1,241,580.00 | (3%) 1.97M to 1.91M | |
19-Dec-22 5:56 PM View: | 4d Molecular Therapeutics, ... (FDMT) | 15-Dec-22 | Private Sale (Planned) | 32,933 | $23.59 | $776,767.00 | (2%) 2.0M to 1.97M |